Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Cytrellis ellacor System with Micro-Coring Technology-Dermal Micro-Coring System System intended Recalled by Cytrellis Biosystems, Inc. Due to Irregular core patterns could cause potential overlap of...

Date: April 7, 2023
Company: Cytrellis Biosystems, Inc.
Status: Completed
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Cytrellis Biosystems, Inc. directly.

Affected Products

Cytrellis ellacor System with Micro-Coring Technology-Dermal Micro-Coring System System intended for the treatment of moderate and severe wrinkles in the mid and lower face. Model #: Gen 4

Quantity: 89 units

Why Was This Recalled?

Irregular core patterns could cause potential overlap of cores at the 8% setting, potentially leading to prolonged healing, irregularities in patient skin texture post-treatment, and/or scarring.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Cytrellis Biosystems, Inc.

Cytrellis Biosystems, Inc. has 2 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report